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Background: The aim of this study was to assess the associations between child maltreatment 
(CM), psychopathological symptoms, and onset of diabetes mellitus, hypothyroidism (i.e., 
low metabolism), and chronic bronchitis/emphysema/COPD in adulthood.  
Methods: The present analysis used data collected in 2007-2008 within the framework of the 
Tromsø Study, Norway (N=12,981). CM was measured with a single item, and self-reported 
information on psychopathological symptoms and physical health outcomes was used. The 
association between CM, psychopathological symptoms, and physical health outcomes was 
assessed with linear and Poisson regression models. Mediation was assessed with difference-
in-coefficients methods.  
Results: In the fully-adjusted models, CM was associated with higher levels of anxiety and 
depression, psychological distress, sleeping difficulty, insomnia, and use of sleeping pills or 
antidepressants in adulthood (p<0.05). Moreover, CM was associated with a more than two-
folds increased risk of consultation with psychiatrist (p<0.001), a 26% increased risk of 
forgetfulness (p<0.001), a 15% increased risk of decline in memory (p<0.001), and a 96% 
increased risk of psychiatric problems (p<0.001) over the course of life. In the fully-adjusted 
models, CM was associated with a 27- 82% increased risk of physical health outcomes in 
adulthood (p<0.05). Indicators of psychopathological symptoms significantly (p<0.05) 
mediate the associations between CM and physical health outcomes.  
Limitations: The design of this study is cross-sectional, and all measures are self-reported. 
Conclusion: The associations between retrospectively-reported CM and physical health 
outcomes in adulthood are partially driven by psychopathological symptoms in adulthood.  
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There is a growing body of evidence that disease suffered in adulthood may originate from 
maltreatment in childhood (Baumeister et al., 2015; Hostinar et al., 2017; Springer et al., 
2003). A recent meta-analysis showed that child maltreatment (CM) contributes to potentially 
pathogenic pro-inflammatory state in adulthood (Baumeister et al., 2015). The hypothalamic-
pituitary-adrenocortical (HPA) axis and neuro-endocrine system helps regulate our stress 
response, and our immune system (Smith and Vale, 2006). Any disruption to the HPA axis 
and the neuro-endocrine system affects a range of psychological and physiological functions 
(Coates, 2010; Teicher et al., 2002). Prolonged or profound stressful experiences in life, such 
as CM may modify the neuro-endocrine stress response systems (Coates, 2010; Gee and 
Casey, 2015; Hellhammer and Wade, 1993; Teicher et al., 2002). Indeed, previous evidence 
suggests that chronic stress, caused by CM has a long-term influence on several physiological 
processes via dysregulation of the inflammatory system (Anda et al., 2006; Baumeister et al., 
2015; Coates, 2010; Danese and McEwen, 2012; Heffner, 2011; Hellhammer and Wade, 
1993; Hostinar et al., 2017; McEwen, 2000; Sheikh, 2018d). Other evidence suggests that 
child maltreatment places stress on the endocrine system, leading to impairment of important 
hormones that can contribute to obesity (De Bellis and Zisk, 2014; Joung et al., 2014). In turn, 
obesity is associated with a wide range of physical health outcomes including diabetes 
mellitus (Sheikh et al., 2014). Indeed, previous evidence suggests that CM is associated with 
stress dysregulation, immune dysfunction, and inflammation in later life (Coates, 2010; 
Fagundes et al., 2013; Yang et al., 2017), which may confer increased vulnerability to several 
physical health outcomes (Anda et al., 2006; Felitti Md et al., 1998; Hostinar et al., 2017; 
Sheikh, 2018a, d). Moreover, several studies suggest a bidirectional communication between 
the brain and the immune system (Danese and McEwen, 2012; Lorton et al., 2006; Nusslock 
and Miller, 2016; Procaccini et al., 2014). Other studies have shown that CM is associated 
 
 
with an increased risk of diabetes mellitus, hypothyroidism (i.e., low metabolism), and 
chronic obstructive pulmonary disease (COPD) in adulthood (Duncan et al., 2015; Felitti Md 
et al., 1998; Kalmakis and Chandler, 2015; Plaza et al., 2012; Post et al., 2013; Rich-Edwards 
et al., 2010; Sheikh, 2018a, d; Shields et al., 2016). 
CM may affect psychopathological symptoms (Sheikh, 2018a, f; Teicher and Samson, 
2013), which in turn may affect (directly, or indirectly via medication) physical health 
outcomes (Danese and McEwen, 2012; Mock and Arai, 2011; Pan et al., 2010; Rubin et al., 
2008; Scott et al., 2011; Sheikh, 2018d; Yoon et al., 2013). Indeed, elevated levels of 
inflammatory markers have been reported in individuals with psychopathological symptoms 
(Baumeister et al., 2014; Coccaro et al., 2014), and among those with a history of CM 
(Coelho et al., 2013). Accordingly, mental health may also mediate the association between 
CM and physical health. The mediation model (i.e., CMmental healthphysical health) has 
convincing support from previous longitudinal studies and could be most plausible for 
physical health outcomes that are “stress-related” such as COPD. Indeed, previous evidence 
suggests that poor mental health is associated (directly or indirectly via medication) with an 
increased risk of a wide range of physical health outcomes (Blanchette et al., 2008; Cohen et 
al., 2000; Correll et al., 2015; Correll et al., 2017; Coupland et al., 2011; Hippisley-Cox et al., 
2001; Huang et al., 2017; Mock and Arai, 2011; Pan et al., 2010; Rubin et al., 2008; Scott et 
al., 2011; Tata et al., 2005; Vancampfort et al., 2015; Yoon et al., 2013). For instance, use of 
tricyclic tranquilizers can cause metabolic syndrome (Van Reedt Dortland et al., 2010). 
Similarly, depression (Pan et al., 2010), and use of antidepressants (Pan et al., 2010; Rubin et 
al., 2008; Yoon et al., 2013) are independently associated with an increased risk of diabetes 
mellitus. Other evidence demonstrated that antipsychotic medication is associated with a 
higher risk for cardio-metabolic diseases (Correll et al., 2015; Correll et al., 2017; 
Vancampfort et al., 2015). Accordingly, several studies using a variety of mental and physical 
 
 
health indicators, including biological indices has shown that mental health mediates the CM-
physical health association (Mock and Arai, 2011; Scott et al., 2011).  
The aim of this study was to assess (1) the association between CM and 
psychopathological symptoms in adulthood; (2) the association between CM and three 
physical health outcomes (diabetes mellitus, hypothyroidism, and COPD in adulthood, and; 






The Tromsø Study is a longitudinal prospective cohort study and its participants are 
considered representative of the adult population residing in the municipality of Tromsø 
(Jacobsen et al., 2012). The present analysis includes cross-sectional data collected for 
Tromsø VI in 2007-2008; 19,762 subjects were invited and 12,981 (65.7%) returned the 
questionnaire (Sheikh, 2018d). To preserve temporality between CM and physical health 
outcomes in adulthood, we excluded respondents that may have been diagnosed with these 
physical outcomes in childhood (Sheikh, 2018d). Accordingly, respondents that reported a 
diagnosis of diabetes mellitus (n=53), hypothyroidism (n=88), and COPD (n=325) before the 
age 18 years were excluded. The remaining study samples used in the analysis were: 
n=12,928 for CMdiabetes mellitus association; n=12,893 for CMhypothyroidism 
association, and; n=12,656 for CMCOPD association. 
 
Ethical approval 
This investigation was carried out in accordance with the latest version of the Declaration of 
Helsinki. The Tromsø Study has been approved by the Regional Committee for Medical and 
Health Research Ethics, the Data Inspectorate, and the Norwegian Directorate of Health. 
Written informed consent was obtained from all participants included in the study. 
 
Study variables  
Exposure (childhood maltreatment) 
Information on childhood maltreatment (Sheikh, 2018c) were obtained through the question: 
“Have you over a long period experienced the following as a child?: being beaten, kicked, or 
 
 
the victim of other types of violence”. Those responding positively to the question were 
considered as maltreated in childhood.  
 
Outcome (physical health outcomes)  
The questions on self-reported diagnosis of three physical health outcomes: diabetes mellitus, 
hypothyroidism, and chronic bronchitis/emphysema/COPD were included in the 
questionnaire. Participants completed a separate question for each health outcome, as follows: 
“Do you have, or have you had [physical health outcome]?”. Other physical outcomes, such 
as cancer were not measured in Tromsø Study.  
 
Confounding variables 
The potential confounding variables age, sex, parental history of psychiatric disorders, 
diabetes mellitus, dementia, and asthma were chosen based on a priori knowledge of the 
correlates of CM and physical health outcomes in adulthood (Sheikh, 2018a, c, d). Valid 
information on age and sex was obtained from Statistics Norway by using the unique personal 
identification number of each participant. 
 
Indicators of current psychopathological symptoms 
Current psychopathological symptoms was assessed by several questions on anxiety; 
depression; insomnia; psychological distress; use of sleeping pills, antidepressants, and 
tranquilizers; memory problems; and prevalence of psychiatric problems (Sheikh, 2018d). 
Anxiety and depression was measured by a question with three response alternatives (1=I am 
not anxious or depressed, 2=I am somewhat anxious or depressed, 3=I am very anxious or 
depressed). Depression was also measured by the question: “Have you been feeling unhappy 
and depressed during the past two weeks?”, with four possible responses (1=not at all, 2=no 
 
 
more than usual, 3= rather more than usual, 4=much more than usual). Psychological distress 
during the last week was measured using the Hopkins Symptom Checklist (HSCL-10) 
(Sheikh, 2018b, e; Sheikh et al., 2018). The HSCL-10 consists of 10 items on a four-point 
scale, ranging from not at all (1) to extremely (4). The HSCL-10 had an acceptable degree of 
internal consistency in this sample (Cronbach’s alpha: 0.87, mean inter-item correlation: 0.42, 
McDonald’s omega coefficient for composite reliability: 0.87) (Sheikh, 2018e). An HSCL-10 
score between 10 and 40 was calculated by summing the 10 indicators, where 40 represented 
the highest and 10 represented the lowest score for psychological distress (mean: 12.78, SD: 
3.60). Sleeping difficulty was measured by the question: “Have you had difficulty sleeping 
during the past couple of weeks?” (1=not at all, 2=no more than usual, 3=rather more than 
usual, 4=much more than usual). Insomnia was measured by the question: “How often do you 
suffer from sleeplessness?” (1=never, or just a few times a year, 2=1-3 times a month, 
3=approximately once a week, 4=more than once a month). Consultation with a psychiatrist 
was measured by the question: “Have you during the past year visited a psychiatrist?” (0=no, 
1=yes). Use of sleeping pills, antidepressants and tranquilizers was measured by three 
separate questions: “How often have you used sleeping pills/antidepressants/tranquilizers 
during the last 4 weeks?” (1=not used, 2=less frequently than every week, 3=every week, but 
not daily, 4=daily). Forgetfulness was measured by the question: “Do you often forget where 
you have placed your things?” (0=no, 1=yes), and decline in memory was measured by the 
question: “Has your memory declined?” (0=no, 1=yes). Memory examination was measured 
by the question: “Have you been examined for memory problems?” (0=no, 1=yes). 
Prevalence of psychiatric problems was measured by the question: “Do you have, or have you 





All statistical analyses were conducted using Stata version 15. Missing values were generated 
with multiple imputation (with chained equations) to avoid any bias in the association of 
interest introduced by excluding individuals with missing data (Sheikh, 2018d). A comparison 
between the complete-case (excluding missing) and the imputed datasets is presented with 
proportions (%), and mean (standard error, SE) (Sheikh, 2018d). We estimated Pearson 
product-moment correlations between physical health outcomes (see Table 1). No statistically 
significant multiplicative interactions between CM and confounding variables or indicators of 
current psychopathological symptoms were observed. The association between CM and 
current psychopathological symptoms was assessed with ordinary least square (OLS) 
regression models (for continuous or ordinal outcomes) and Poisson regression models (for 
binary outcomes) (see Table 2). The association between psychopathological symptoms and 
physical health outcomes (see Table 3), and between CM and physical health outcomes (see 
Table 4 and Table 5) were assessed with Poisson regression models (Sheikh, 2018d, f). 
Relative risks (RRs) and corresponding 95% CIs were estimated.  
 
Assessing mediation via current psychopathological symptoms 
Potential mediation via psychopathological symptoms was assessed with the difference-in-
coefficients method (Sheikh, 2018b, d, f). Indicators of current psychopathological symptoms 
were included in the models to assess the indirect effects (Sheikh, 2018d). In order to assess 
whether a specific set of psychopathological symptoms play a stronger role in the association 
between CM and physical health, we divided psychopathological symptoms in three 
categories: affective symptoms (anxiety and depression, depression, sleeping difficulty, 
insomnia, use of sleeping pills, and use of antidepressants); general mental health 
(consultation with psychiatrist, use of tranquilizers, and prevalence of psychiatric problems); 
and deficits in memory (forgetfulness, decline in memory, and memory examination). SEs 
 
 
were derived with bias-corrected bootstrapping (Sheikh, 2018b, d, f) for hypothesis testing, 





Over 2.8% of the respondents reported having a consultation with a psychiatrist during 
the past year, and 10.6% reported prevalence of psychiatric problems (Table S1). In this 
sample, 800 (6.2%) participants reported childhood maltreatment (Table S1). The prevalence 
of physical health outcomes were: 4.7% for diabetes mellitus, 8.5% for hypothyroidism, and 
2.8% for COPD (Table S1). Indicators of physical health outcomes were significantly 
(p<0.001) associated with each other in the predicted direction (Table 1).  
In the fully-adjusted models, accounting for age, sex, and parental history of chronic 
conditions, CM was associated with higher levels of anxiety and depression (β=0.12, 95% CI: 
0.09, 0.16; p<0.001), depression (β=0.26, 95% CI: 0.21, 0.31; p<0.001), psychological 
distress during the past week (β=1.70, 95% CI: 1.37, 2.02; p<0.001), difficulty in sleeping 
during the past couple of weeks (β=0.20, 95% CI: 0.15, 0.25; p<0.001), insomnia (β=0.33, 
95% CI: 0.25, 0.41; p<0.001), use of sleeping pills (β=0.08, 95% CI: 0.03, 0.13; p<0.001), 
and use of antidepressants (β=0.05, 95% CI: 0.01, 0.10; p<0.05) during the last four weeks 
(Table 2). Similarly, CM was associated with a more than two-fold increased risk of 
consultation with psychiatrist during the past year (RR=2.15, 95% CI: 1.60, 2.87; p<0.001), a 
26% increased risk of forgetfulness (RR=1.26, 95% CI: 1.13, 1.40; p<0.001), a 15% increased 
risk of memory examination (RR=1.15, 95% CI: 1.07, 1.23; p<0.001), and a 96% increased 
risk of self-reported psychiatric problems over the course of life (RR=1.96, 95% CI: 1.69, 
2.26; p<0.001) (Table 2). Table 3 shows that indicators of psychopathological symptoms are 
associated with diabetes mellitus, hypothyroidism, and COPD in adulthood (cross-sectional 
association). 
Controlling for age, sex, and parental history of chronic conditions, CM was 
associated with a 47% increased risk of diabetes mellitus (RR=1.47, 95% CI: 1.10, 1.91), a 
 
 
42% increased risk of hypothyroidism (RR=1.42, 95% CI: 1.13, 1.78), and a more than two-
fold increased risk of COPD (RR=2.19, 95% CI: 1.49, 3.04) (Table 4).  
Indicators of current psychopathological symptoms significantly mediate the 
association between CM and physical health outcomes; however, the direct effects remained 
statistically significant (p<0.05) in the same direction (Table 4). In the fully-adjusted models, 
CM was associated (direct effects) with an increased risk of diabetes mellitus (RR=1.38, 95% 
CI: 1.04, 1.79), hypothyroidism (RR=1.27, 95% CI: 1.03, 1.56), and COPD (RR=1.82, 95% 
CI: 1.28, 2.56) (Table 4).  
Table 5 presents the indirect effects separately for affective symptoms, general mental 
health, and deficits in memory. ‘Affective symptoms’ was a more significant mediator than 
‘general mental health’ and ‘deficits in memory’ (Table 5). Moreover, ‘general mental health’ 







We sought to evaluate the associations between CM, psychopathological symptoms, 
and physical health outcomes in a large cross-sectional sample of the general Norwegian 
population. CM was associated with an increased risk of psychopathological symptoms and 
onset of diabetes mellitus, hypothyroidism, and COPD in adulthood. The results showed that 
inclusion of indicators of psychopathological symptoms attenuated the relationship between 
CM and physical health outcomes in adulthood; however, the direct effects remained 
statistically significant in the same direction. Although, only three items measured ‘deficits in 
memory’, the weak indirect effects may suggest that a major limitation of the association 
between retrospectively-reported CM and physical health is not inaccuracy of memory. 
However, the psychopathological symptoms measured in this study do not consider patients 
such as those who develop dementia or Alzheimer's disease later in life. It must be noted that 
psychopathological symptoms itself may in fact be a somatic illness with the inflammatory 
processes occurring in the brain rather than in another anatomical region. Given the 
established links between the brain and the immune system (Danese and McEwen, 2012; 
Lorton et al., 2006; Nusslock and Miller, 2016; Slavich et al., 2010; Vogelzangs et al., 2013), 
it is plausible to assume that the direct effects presented here may reflect the impact of CM on 
physical health outcomes, independent of inflammatory processes in the brain.  
Although ours is not the first study to examine the mediating role (Mock and Arai, 
2011; Scott et al., 2011) of psychopathological symptoms in the association between CM and 
physical health outcomes in adulthood (Sheikh, 2018d), the present study offered three 
advantages. First, we used a priori selection of variables for confounding. Second, we 
assessed the associations in a large representative sample of adult men and women. Third, we 
included a wide range of indicators to assess the current psychopathological symptoms. 
Although, this study did not explore the specific mechanisms via dysregulation of neuro-
 
 
endocrine system, immune system, inflammation and cortisol levels, these findings are 
consistent with previous evidence on the long-term effects of CM on mental and physical 
health outcomes in adulthood. 
CM and physical health outcomes were measured retrospectively. The design of this 
study is cross-sectional; therefore, the temporal associations cannot be ascertained with 
certainty. Self-reported physical health outcomes could have differed from medical diagnoses 
made by physicians. Since the present study had a cross-sectional design, there was a 
potential for upward bias in estimates due to shared-method variance that cannot be ignored 
(Sheikh, 2018b, c, d, e). Although Tromsø Study is a prospective cohort study, we used data 
from a cross-sectional wave (Tromsø VI) because CM was not measured in other waves. The 
measurement of CM relies on a single item; therefore, it is limited in scope and utility. Other 
indicators of childhood adversity, such as sexual abuse, separation of parents, witnessing 
domestic violence in the home, living with someone with psychiatric disorders, living with 
someone who has been incarcerated, etc., were not measured in the Tromsø Study (Sheikh, 
2018f). Moreover, the measurement of CM does not provide an account of perpetrator, or the 
extent or duration of maltreatment. Accordingly, it is likely that there is a considerable non-
differential measurement error in CM, which might result in an under-estimation (biased 
downwards) of its association with physical health outcomes (Fosgate, 2006). The 
measurement error in CM is not limited due to its retrospectively recall but may reflect 
differences is what is understood “as victim of other types of violence” (Sheikh, 2018d). 
Indeed, even if one accounts for the current psychopathological symptoms, we cannot exclude 
the possibility that there is measurement error in the CM variable (Cerdá et al., 2012; Weis, 
1989). Consequently, it is likely that a reliable measure of CM would lead to stronger 
associations with physical health outcomes. A reliable instrument for measuring CM could 
also strengthen the argument that mental health mediates the association between CM and 
 
 
physical health in adulthood. Another limitation of this study is that measurement of physical 
health outcomes also relied in self-reports (Cigolle et al., 2016). Matching the survey data 
from the Tromsø Study with administrative/population register data on individual health 
outcomes could strengthen the argument that CM is associated with these physical health 
outcomes. Specific type of diabetes mellitus was not measured in the questionnaire; therefore, 
the associations presented here applies to cases of both type 1 and type 2 diabetes mellitus.  
It must be noted that the possibility of unmeasured or unaccounted-for intermediate 
confounding cannot be ruled out. For instance, mental health in childhood and adolescence 
may affect both mental and physical health in adulthood, and could itself be affected by CM. 
Unless the intermediate confounding is tackled, the support for mediation hypothesis as a 
causal mechanism will remain questionable (Kaufman, 2009; Kaufman et al., 2004; Naimi et 
al., 2014). On the other hand, even though causal inference about the mediating hypothesis 
remains questionable, the potential biological pathways cannot be ignored.  
In summary, the results of this study showed that CM is associated with an increased 
risk of psychopathological symptoms and onset of diabetes mellitus, hypothyroidism, and 
chronic bronchitis/emphysema/COPD in adulthood. Moreover, indicators of 
psychopathological symptoms significantly attenuated the associations between CM and 
physical health outcomes. These findings suggest that CM affects physical health, both 
directly (i.e., independent of psychopathological symptoms) and indirectly (via 
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 1 3 5
 r r r
1. Diabetes mellitus 1.00
3. Hypothyroidism 0.05 a 1.00
5. COPD 0.07 a 0.08 a 1.00
 
 






































a Adjusted for age, sex, parental history of health outcomes (psychiatric disorders, diabetes 
mellitus, and asthma). 
b p < 0.001 
c p < 0.01 
d p < 0.05 
e p < 0.1 
RR: relative risk; CI: confidence interval.  
 
  
 Anxiety and depression 

















β (95% CI) β (95% CI)
0.12 (0.09, 0.15) b 0.12 (0.09, 0.16) b 
Depression 
0.26 (0.21, 0.31) b 0.26 (0.21, 0.31) b 
Psychological distress (HSCL-10)
1.64 (1.30, 1.97) b 1.70 (1.37, 2.02) b 
Sleeping difficulty 
0.17 (0.12, 0.22) b 0.20 (0.15, 0.25) b 
Insomnia
0.26 (0.18, 0.34) b 0.33 (0.25, 0.41) b 
Consultation with psychiatrist
RR (95% CI) RR (95% CI)
2.42 (1.80, 3.24) b 2.15 (1.60, 2.87) b 
Use of sleeping pills
β (95% CI) β (95% CI)
0.03 (-0.01, 0.08) 0.08 (0.03, 0.13) b 
Use of antidepressants
0.05 (0.01, 0.09) d 0.05 (0.01, 0.10) d 
Use of tranquilizers
0.01 (-0.02, 0.04) 0.02 (-0.01, 0.04) 
Forgetfulness
RR (95% CI) RR (95% CI)
1.18 (1.06, 1.31) c 1.26 (1.13, 1.40) b 
Decline in memory
1.07 (1.00, 1.14) e 1.15 (1.07, 1.23) b 
Memory examination
1.08 (0.59, 2.00) 1.18 (0.63, 2.20) 
Prevalence of psychiatric problems 
2.11 (1.82, 2.44) b 1.96 (1.69, 2.26) b 
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a Adjusted for age, sex, child maltreatment, and parental history of health outcomes (psychiatric disorders, diabetes mellitus, and asthma) 
b p < 0.001 
c p < 0.01 
d p < 0.05 
e p < 0.1 
RR: relative risk; CI: confidence interval.  
 Diabetes mellitus Hypothyroidism COPD 
 RR (95% CI) a RR (95% CI) a RR (95% CI) a 
Anxiety and depression 1.58 (1.33, 1.88) b 1.34 (1.19, 1.51) b 1.95 (1.67, 2.27) b 
Depression 1.30 (1.16, 1.46) b 1.20 (1.11, 1.30) b 1.52 (1.37, 1.68) b 
Psychological distress (HSCL-10) 1.05 (1.04, 1.07) b 1.04 (1.03, 1.05) b 1.10 (1.09, 1.11) b 
Sleeping difficulty 1.10 (0.98, 1.23) 1.18 (1.09, 1.27) b 1.40 (1.26, 1.55) b 
Insomnia 1.07 (1.00, 1.15) e 1.10 (1.04, 1.15) b 1.36 (1.27, 1.45) b 
Consultation with psychiatrist 1.54 (0.97, 2.45) e 1.34 (0.99, 1.83) e 1.68 (1.02, 2.77) d 
Use of sleeping pills 1.05 (0.93, 1.17) 1.14 (1.06, 1.23) b 1.38 (1.27, 1.51) b 
Use of antidepressants 1.14 (1.00, 1.29) e 1.14 (1.04, 1.24) c 1.31 (1.16, 1.47) b 
Use of tranquilizers 1.25 (1.08, 1.43) c 1.11 (1.01, 1.24) d 1.45 (1.29, 1.63) b 
Forgetfulness 1.04 (0.88, 1.23) 1.14 (1.01, 1.29) d 1.36 (1.13, 1.64) b 
Decline in memory 1.04 (0.89, 1.23) 1.16 (1.02, 1.31) d 1.28 (1.07, 1.53) c 
Memory examination 1.58 (1.00, 2.50) d 1.82 (1.32, 2.51) b 1.59 (0.91, 2.76) e 
Prevalence of psychiatric problems 1.66 (1.33, 2.08) b 1.60 (1.37, 1.87) b 2.05 (1.64, 2.56) b 
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Table 4. Influence of current psychopathological symptoms on the association between childhood maltreatment 












a Adjusted for age, sex, parental history of health outcomes (psychiatric disorders, diabetes 
mellitus, and asthma) 
b Adjusted for age, sex, parental history of health outcomes (psychiatric disorders, diabetes 
mellitus, and asthma)+ current psychopathological symptoms (anxiety, depression, 
psychological distress (HSCL-10), sleeping difficulty, insomnia, consultation with psychiatrist, 
use of sleeping pills, use of antidepressants, use of tranquilizers, forgetfulness, decline in 
memory, and memory examination).  






 Diabetes mellitus 
 Total effect a Direct effect b Indirect effect 
 RR (95% CI) RR (95% CI) RR (95% CI) 
 1.47 (1.10, 1.91) 1.38 (1.04, 1.79) 1.07 (1.02, 1.12) 
Childhood maltreatment Hypothyroidism
1.42 (1.13, 1.78) 1.27 (1.03, 1.56) 1.12 (1.07, 1.17) 
 COPD
 2.19 (1.49, 3.04) 1.82 (1.28, 2.56) 1.21 (1.12, 1.36) 
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Table 5. The indirect effect of childhood maltreatment on physical health outcomes via affective symptoms, 
























a Adjusted for age, sex, parental history of health outcomes (psychiatric disorders, diabetes 
mellitus, and asthma) 
RR: relative risk; CI: confidence interval.  
 Indirect effect  
 RR (95% CI) a 
 Diabetes mellitus 
Via affective symptoms 1.09 (1.05, 1.16) 
Via general mental health 1.02 (1.01, 1.05) 
Via deficits in memory 1.00 (1.00, 1.01) 
 Hypothyroidism 
Via affective symptoms 1.08 (1.05, 1.10) 
Via general mental health 1.05 (1.04, 1.07) 
Via deficits in memory 1.02 (1.00, 1.02) 
 COPD 
Via affective symptoms 1.19 (1.09, 1.37) 
Via general mental health 1.01 (0.94, 1.03) 
Via deficits in memory 1.03 (1.01, 1.05) 
